Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy (opens ClinicalTrials.gov)
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Enrolment
- 68
- Started
- 2025-05-07
- Last update
- 2026-10-13
Conditions: Pancreatic Adenocarcinoma Metastatic
Interventions: Niraparib, FOLFIRI, Ipilimumab